How Deep Learning in AI Is Reshaping Cancer Research Beyond Prostate Imaging
Expanding the Role of Deep Learning in Cancer Detection
Deep learning, a powerful subset of artificial intelligence (AI), has fundamen...
All Posts
How Machine Learning is Powering Modern AI Cancer Research at Bot Image
Advancements in artificial intelligence (AI) are revolutionizing the field of cancer research, and Bot Image stands at the forefront of...
An Overview of Prostate Cancer Detection Standard of Care and The Role of MRI for Early Detection of Prostate Cancer
Randall W. Jones, D.Eng. (PhD, MBA)
EARLY DETECTION through Screening
Population-Based Screening Studies
Screening for Prostate Canc...
The Use Of Prostatid In Cancer Detection, Diagnosis And Screening
Overview: ProstatIDTM is North America’s first FDA-Cleared Prostate Cancer SCREENING, Detection and Diagnostic AI software. With 94% AU...
ConcertAI’s TeraRecon and Bot Image, Inc. Partnership
TeraRecon, on March 18, 2023
CAMBRIDGE, Mass., Mar. 18,2023 /PRNewswire/ -- The Eureka Clinical AI platform, from ConcertAI's Tera...
Omaha-Based MRI Medical Device Company, Bot Image, Receives FDA Clearance for AI
FOR IMMEDIATE RELEASE Bot Image, an Omaha-based MRI medical device company has developed an AI-driven medical device CAD software to...
Just released by Dr. Randall W Jones
Just released, The Healthcare Disruptor, by Dr. Randall W Jones. Dr. Jones writes about his journey from rural cowboy to medical device expert and CEO challenging the healthcare system with his inventions...
Bot Image Makes the List: 10 Most Advanced Medical Imaging Solution Providers 2022
Bot Image Inc: Facilitating Early Detection through Disruptive Technology In undetermined and unsettled times, one must be open to...
A Trailblazing Entrepreneur, Bringing Highly Accurate MRI Interpretation Software to Physicians
DR. RANDALL W. JONES FOUNDER & CEO OF BOT IMAGE, INC From joining the military at a young age to excelling at civilian jobs to...
Prostate Cancer Treatment can be safely delayed and inexpensively and accurately monitored thanks to AI
Bot Image, Inc., a Nebraska and Maine based Artificial Intelligence medical device company, has received FDA-clearance on its ProstatID...